Eupraxia Pharmaceuticals (EPRX) Receivables - Other (2022 - 2026)
Eupraxia Pharmaceuticals' Receivables - Other came in at $688,219 for the quarter ended Jun 30, 2026, up 411.3% from $134,607 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Receivables - Other (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Receivables - Other was $674,226, up 194.6% from the prior year.
- Receivables - Other has increased in each of the last three years, with a three-year compound annual growth rate of 95.9% (years ended Dec 2022 to Dec 2025).
- Going back by year, Receivables - Other was $228,872 in the year ended Dec 31, 2024 (+20.1%), $190,612 in the year ended Dec 31, 2023 (+112.5%) and $89,715 in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Receivables - Other in data going back to the quarter ended Dec 31, 2022.
- Year-over-year, Receivables - Other has increased for four consecutive quarters, with growth averaging 123.6% over the last seven quarters.
- The fastest year-over-year change in Receivables - Other over five years came in the quarter ended Jun 30, 2026 (growth of 411.3%), and the weakest in the quarter ended Jun 30, 2025 (a decline of 13.3%).
- Business Quant data shows EPRX's Receivables - Other at $663,235 (quarter ended Mar 31, 2026), $674,226 (quarter ended Dec 31, 2025) and $139,904 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 688,219.00 |
| Mar 31, 2026 | 663,235.00 |
| Dec 31, 2025 | 674,226.00 |
| Sep 30, 2025 | 139,904.00 |
| Jun 30, 2025 | 134,607.00 |
| Mar 31, 2025 | 238,531.00 |
| Dec 31, 2024 | 228,872.00 |
| Sep 30, 2024 | 105,930.00 |
| Jun 30, 2024 | 155,235.00 |
| Mar 31, 2024 | 167,243.00 |
| Dec 31, 2023 | 190,612.00 |
| Dec 31, 2022 | 89,715.00 |
API Access
Eupraxia Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();